Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
- Conditions
- Transplant; Complication, RejectionLiver Diseases, AlcoholicHepatitis, AlcoholicLiver DiseasesAlcohol-Induced DisordersAlcohol-Related DisordersTransplant; Failure, Liver
- Interventions
- Procedure: liver transplant
- Registration Number
- NCT04234139
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The purpose of this study is to develop a clinical understanding of early liver transplantation (ELT) for patients with severe alcoholic hepatitis (SAH) and identify the public's opinion regarding this practice.
- Detailed Description
The research study is designed to improve the investigators' understanding of early liver transplantation for patients with severe alcoholic hepatitis. The goal of this research is twofold:
1. Establish a knowledge base necessary for appropriate liver transplant candidate selection by quantifying post-ELT mortality for SAH and compare to outcomes to liver transplantation for other indications
2. Develop an ethical framework for implementation of these transplants for SAH based on the opinions of healthcare providers and the general public.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 300
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Prospective Cohort 2 liver transplant Orthotopic Liver Transplantation (OLT) in patient who present with Alcoholic Liver Disease (ALD) Prospective Cohort 1 liver transplant Early Liver Transplantation (ELT) for patients who present with Severe Alcoholic Hepatitis (SAH) Retrospective Cohort liver transplant Early Liver Transplantation (ELT) for patients who presented with Severe Alcoholic Hepatitis (SAH)
- Primary Outcome Measures
Name Time Method Number of participants who survived within 1 year post-transplant 1 years Post-transplant survival within one year of the surgical procedure.
- Secondary Outcome Measures
Name Time Method Number of participants who self-report or have biochemically measured alcohol recidivism or relapse within 1 year post-transplant 1 years Self-reported or biochemically measured alcohol recidivism or relapse.
Trial Locations
- Locations (1)
Johns Hopkins University
🇺🇸Baltimore, Maryland, United States